Ambiq Micro, Inc.
NYSE:AMBQSemiconductors
+$5.10 today
- Market cap
- $1.14B
- Beta
- 5.68
- P/E (TTM)
- -44.8
- EPS (TTM)
- -$1.88
Volume 0.30M
Average 0.58M
AMBQ Operating Cash Flow
Cash generated by the company's core business operations during the period.
Ambiq Micro, Inc.NYSE: AMBQ
Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Operating cash flow turns negative
Q1 FY2026 operating cash flow was -$11.17M, compared with $1.41M a year earlier. Trailing-twelve-month operating cash flow was -$32.27M.
Context
- Operating cash flow amounted to 27.2% of revenue in FY2025, down 1.0 pp from a year earlier.
- Operating cash flow grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly operating cash flow holds near -$11.17M or moves back toward the trailing-twelve-month quarterly average of -$8.07M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (19.69M) USD
- Year-over-year change
- +8.1%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (19.69M) | +8.1% |
| FY2024 | 2024-12-31 | (21.43M) | +20.5% |
| FY2023 | 2023-12-31 | (26.96M) | — |
| FY2021 | 2021-12-31 | (52.88M) | -52.7% |
| FY2020 | 2020-12-31 | (34.64M) | — |
Operating Cash Flow vs competitors
How AMBQ compares with its peers on the latest reported figures
- Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +88.0% is the 3rd highest of 10, against a peer median of +11.7%.
- Operating cash flow amounts to 39.4% of revenue for AMBQ, versus a peer median of 15.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $363.2M USD | -32.2% | +66.5% | 51.0% | |
| LTM Mar 2026 | $88.45M USD | +102.5% | — | 29.3% | |
| LTM Mar 2026 | $73.76M USD | +65.2% | +26.5% | 182.7% | |
AMBQAmbiq Micro, Inc. | LTM Mar 2026 | $32.27M USD | +88.0% | — | 39.4% |
| LTM Mar 2026 | $30.91M USD | +11.7% | +36.1% | 2189.7% | |
| LTM Mar 2026 | $22.52M USD | +60.5% | — | 15.0% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥13.15M CNY | — | -73.5% | — |
| LTM Mar 2026 | $12.05M USD | -64.2% | — | 4.8% | |
| LTM Apr 2026 | $9.15M USD | +227.0% | — | 2.9% | |
| LTM Jun 2026 | $5.76M USD | -52.3% | +13.4% | 4.6% | |
| LTM Mar 2026 | $3.19M USD | -291.8% | — | 4.1% | |
| Peer median (excluding AMBQ) | — | +11.7% | +26.5% | 15.0% | |
Competitors are the stored peer set for AMBQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (25.22M) | (25.34M) | (50.33M) | (39.66M) | (36.46M) |
| Depreciation & Amortization | 1.93M | 2.61M | 7.72M | 6.25M | 7.22M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 702K | 1.29M | 2.62M | 5.17M | 6.84M |
| Change in Working Capital | (16.89M) | (36.58M) | 12.91M | 5.11M | 3.47M |
| Accounts Receivables | (136K) | (10.88M) | (2.98M) | 1.75M | 3.23M |
| Inventory | (3.61M) | (26.46M) | 15.16M | 6.04M | (2.13M) |
| Accounts Payables | (1.55M) | 8.23M | (3.94M) | 821K | 4.2M |
| Other Working Capital | (11.59M) | (7.46M) | 4.67M | (3.51M) | (1.82M) |
| Other Non-Cash Items | 4.84M | 5.14M | 125K | 1.7M | (753K) |
| Operating Cash Flow | (34.64M) | (52.88M) | (26.96M) | (21.43M) | (19.69M) |
| Capital Expenditures | (4.59M) | (4.62M) | (3.02M) | (3.73M) | (1.34M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (1.96M) | 0 | (2.56M) | (3.07M) | (6.1M) |
| Investing Cash Flow | (4.59M) | (4.62M) | (3.02M) | (3.73M) | (7.44M) |
| Debt Repayment | 8.77M | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 58.84M | 109.21M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.35M) | 354K | 516K | 0 | (2.83M) |
| Financing Cash Flow | 94.07M | 18.2M | 31.77M | 58.84M | 106.38M |
| Effect of Forex Changes | (53K) | 176K | (254K) | (24K) | 43K |
| Net Change in Cash | 54.78M | (39.13M) | 1.54M | 33.66M | 79.29M |
| Free Cash Flow | (39.23M) | (57.5M) | (29.98M) | (25.16M) | (21.03M) |
Ambiq Micro, Inc.
NYSE:AMBQ
Intrinsic Alpha fair value
Locked
Current Price
$45.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.